France
# |
Name |
EBITDA Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
34.57%
|
Dec. 31, 2023 | USD 122.64 | 0.35% |
|
France |
|
2 |
32.44%
|
Dec. 31, 2023 | USD 39.47 | -3.91% |
|
France |
|
3 |
31.68%
|
Dec. 31, 2023 | USD 3.97 | 0.60% |
|
France |
|
4 |
27.23%
|
Dec. 31, 2023 | USD 208.18 | -0.28% |
|
France |
|
5 |
26.06%
|
Dec. 31, 2023 | USD 96.09 | -1.23% |
|
France |
|
6 |
22.25%
|
June 30, 2024 | USD 3.36 | -0.01% |
|
France |
|
7 |
21.22%
|
Dec. 31, 2023 | USD 71.52 | -1.80% |
|
France |
|
8 |
20.65%
|
Dec. 31, 2023 | USD 20.08 K | 0.04% |
|
France |
|
9 |
20.24%
|
June 30, 2024 | USD 23.39 | -1.14% |
|
France |
|
10 |
19.07%
|
Dec. 31, 2023 | USD 110.89 | -1.59% |
|
France |
|
11 |
18.79%
|
Dec. 31, 2023 | USD 26.07 | 0.60% |
|
France |
|
12 |
15.46%
|
Dec. 31, 2023 | USD 13.50 | -2.38% |
|
France |
|
13 |
14.94%
|
Dec. 31, 2023 | USD 27.83 | 2.50% |
|
France |
|
14 |
13.94%
|
Dec. 31, 2023 | USD 74.26 | 0.89% |
|
France |
|
15 |
13.40%
|
Dec. 31, 2023 | USD 10.08 | 4.45% |
|
France |
|
16 |
12.89%
|
Dec. 31, 2023 | USD 27.36 | -1.07% |
|
France |
|
17 |
12.30%
|
Dec. 31, 2023 | USD 3.17 | NA |
|
France |
|
18 |
11.68%
|
June 30, 2024 | USD 12.99 | 0.21% |
|
France |
|
19 |
6.97%
|
Dec. 31, 2023 | USD 3.26 | 2.55% |
|
France |
|
20 |
-10.95%
|
Dec. 31, 2023 | USD 2.27 | 11.78% |
|
France |
|
21 |
-11.85%
|
Dec. 31, 2023 | USD 4.54 | 0.83% |
|
France |
|
22 |
-14.60%
|
Dec. 31, 2023 | USD 1.88 | -0.49% |
|
France |
|
23 |
-30.43%
|
Dec. 31, 2023 | USD 2.02 | -2.42% |
|
France |
|
24 |
-37.55%
|
Dec. 31, 2023 | USD 2.16 | -2.19% |
|
France |
|
25 |
-50.59%
|
Dec. 31, 2023 | USD 2.16 | 6.70% |
|
France |
|
26 |
-70.91%
|
Dec. 31, 2023 | USD 1.29 | -1.75% |
|
France |
|
27 |
-77.84%
|
Dec. 31, 2023 | USD 3.40 | -0.30% |
|
France |
|
28 |
-88.12%
|
Dec. 31, 2023 | USD 4.74 | -2.78% |
|
France |
|
29 |
-100.09%
|
Dec. 31, 2023 | USD 3.05 | 0.95% |
|
France |
|
30 |
-135.45%
|
Dec. 31, 2023 | USD 1.50 | -9.33% |
|
France |
|
31 |
-155.83%
|
March 31, 2024 | USD 16.86 | 0.98% |
|
France |
|
32 |
-157.55%
|
Dec. 31, 2023 | USD 0.68 | -1.49% |
|
France |
|
33 |
-198.16%
|
Dec. 31, 2023 | USD 2.05 | -2.81% |
|
France |
|
34 |
-523.35%
|
Dec. 31, 2023 | USD 1.53 | 0.60% |
|
France |
|
35 |
-556.11%
|
Dec. 31, 2023 | USD 4.64 | -14.23% |
|
France |
|
36 |
-583.86%
|
Dec. 31, 2023 | USD 2.29 | 4.37% |
|
France |
|
37 |
-785.86%
|
Dec. 31, 2023 | USD 6.91 | 0.46% |
|
France |
|
38 |
-886.00%
|
Dec. 31, 2023 | USD 8.53 | 3.61% |
|
France |
|
39 |
-900.14%
|
Dec. 31, 2023 | USD 6.08 | 1.81% |
|
France |
|
40 |
-1,090.11%
|
Dec. 31, 2023 | USD 1.42 | -0.83% |
|
France |
|
41 |
-1,202.39%
|
Dec. 31, 2023 | USD 4.25 | 1.59% |
|
France |
|
42 |
-1,584.06%
|
Dec. 31, 2023 | USD 0.96 | -6.39% |
|
France |
|
43 |
-1,729.26%
|
Dec. 31, 2023 | USD 1.82 | 1.18% |
|
France |
|
44 |
-2,882.64%
|
Dec. 31, 2023 | USD 6.25 | -0.54% |
|
France |
|
45 |
-5,031.72%
|
Dec. 31, 2023 | USD 2.22 | -0.32% |
|
France |
|
46 |
-12,269.67%
|
Dec. 31, 2023 | USD 1.74 | -2.29% |
|
France |
The Pharmaceuticals company in France with the highest EBITDA Margin is Ipsen S.A. (Paris Stock Exchange: IPN.PA) at 34.57%.
The Pharmaceuticals company in France with the lowest EBITDA Margin is Cellectis S.A. (Paris Stock Exchange: ALCLS.PA) at -12,269.67%.
The top 10 Pharmaceuticals companies in France by EBITDA Margin are Ipsen S.A., Equasens Société anonyme, genOway Société anonyme, Sartorius Stedim Biotech S.A., Sanofi, Amplitude Surgical SA, Vetoquinol SA, Eurofins-Cerep SA, Bastide Le Confort Médical SA and bioMérieux S.A..
The bottom 10 Pharmaceuticals companies in France by EBITDA Margin are Cellectis S.A., Crossject Société Anonyme, ABIVAX Société Anonyme, PHAXIAM Therapeutics S.A., Neovacs S.A., Predilife S.A., Affluent Medical SA, Adocia SA, MaaT Pharma SA and OSE Immunotherapeutics SA.